Harnessing invariant NKT-cells to enhance antigen specific immune responses

Harnessing invariant NKT-cells to enhance antigen specific immune responses

Detalhes bibliográficos
Autor principal:	Cerundolo, V
Formato:	Journal article
Publicado em:	2014

Registros relacionados

The role of invariant NKT cells in enhancing antigen specific T and B cell responses
por: Cerundolo, V
Publicado em: (2005)

Harnessing invariant NKT cells in vaccination strategies.
por: Cerundolo, V, et al.
Publicado em: (2009)

The role of invariant NKT cells at the interface of innate and adaptive immunity
por: Cerundolo, V
Publicado em: (2010)

Harnessing NKT cells for therapeutic applications.
por: Cerundolo, V, et al.
Publicado em: (2007)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
por: Salio, M, et al.
Publicado em: (2011)

The role of invariant NKT cells at the interface of innate and adaptive immunity.
por: Cerundolo, V, et al.
Publicado em: (2010)

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
por: Dölen, Y, et al.
Publicado em: (2015)

Harnessing Invariant Natural Killer T Cells to Abolish the Suppressive Activity of Myeloid-derived Suppressor Cells and Restore Melanoma-specific Immune Response
por: Cerundolo, V
Publicado em: (2009)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
por: Kotsianidis, I, et al.
Publicado em: (2005)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
por: Kotsianidis, I, et al.
Publicado em: (2006)

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
por: Reddy, BG, et al.
Publicado em: (2009)

Human invariant NKT cells are required for effective in vitro alloresponses.
por: Patterson, S, et al.
Publicado em: (2005)

Description of invariant NKT cells.
por: Katarzyna Karwicka, et al.
Publicado em: (2021-09-01)

The actin cytoskeleton modulates the activation of invariant NKT cells by segregating CD1d nanoclusters on antigen presenting cells
por: Cerundolo, V, et al.
Publicado em: (2016)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
por: Pei, B, et al.
Publicado em: (2011)

Essential role for autophagy during invariant NKT cell development
por: Salio, M, et al.
Publicado em: (2014)

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.
por: Barral, P, et al.
Publicado em: (2008)

Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.
por: Mussai, F, et al.
Publicado em: (2012)

Invariant NKT cell response to dengue virus infection in human.
por: Ponpan Matangkasombut, et al.
Publicado em: (2014-06-01)

Harnessing the power of invariant natural killer T cells in cancer immunotherapy
por: Bedard, M, et al.
Publicado em: (2017)

Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2.
por: Lawson, V, et al.
Publicado em: (2009)

Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection.
por: Ho, L, et al.
Publicado em: (2008)

The location of splenic NKT cells favours their rapid activation by blood-borne antigen.
por: Barral, P, et al.
Publicado em: (2012)

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
por: Hermans, I, et al.
Publicado em: (2003)

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
por: Hermans, I, et al.
Publicado em: (2007)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Melissa Bedard, et al.
Publicado em: (2017-12-01)

The role of invariant natural killer T (iNKT) cells in modulating the lung inflammatory response during influenza A virus infection
por: McEwen-Smith, R, et al.
Publicado em: (2013)

The complement system and invariant natural killer T (iNKT) cell responses
por: Malik, N
Publicado em: (2021)

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
por: Porubsky, S, et al.
Publicado em: (2012)

Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
por: Rebeca Jimeno, et al.
Publicado em: (2019-12-01)

NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer
por: Somayeh Rezaeifard, et al.
Publicado em: (2019-12-01)

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells.
por: Kanako Shimizu, et al.
Publicado em: (2015-01-01)

CD1d expression and invariant NKT cell responses in herpesvirus infections
por: Rusung eTan
Publicado em: (2015-06-01)

Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Masaki Terabe, et al.
Publicado em: (2018-08-01)

Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells
por: Silk, J, et al.
Publicado em: (2008)

Correction: Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
por: Rebeca Jimeno, et al.
Publicado em: (2020-03-01)

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.
por: De Santo, C, et al.
Publicado em: (2010)

Activated invariant NKT cells regulate osteoclast development and function
por: Hu, M, et al.
Publicado em: (2011)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Karsten A. Pilones, et al.
Publicado em: (2012-01-01)

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis
por: Jun-Qi Yang, et al.
Publicado em: (2016-01-01)